BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9160623)

  • 1. Ondansetron in the treatment of panic disorder.
    Schneier FR; Garfinkel R; Kennedy B; Campeas R; Fallon B; Marshall R; O'Donnell L; Hogan T; Liebowitz MR
    Anxiety; 1996; 2(4):199-202. PubMed ID: 9160623
    [No Abstract]   [Full Text] [Related]  

  • 2. Personality dimensions in panic disorder before and after effective treatment.
    Starcevic V; Uhlenhuth EH
    Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
    [No Abstract]   [Full Text] [Related]  

  • 3. The structure of phobias in panic disorder.
    Argyle N; Solyom C; Solyom L
    Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report).
    Slaap BR; van Vliet IM; Westenberg HG; den Boer JA
    J Affect Disord; 1995 Jan; 33(1):31-8. PubMed ID: 7714306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four-dimensional Anxiety and Depression Scale: a preliminary psychometric report.
    Bystritsky A; Waikar SV; Vapnik T
    Anxiety; 1996; 2(1):47-50. PubMed ID: 9160599
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional classification of anxiety-panic.
    Liebowitz MR
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():47-52. PubMed ID: 7902853
    [No Abstract]   [Full Text] [Related]  

  • 8. Attention bias in children of patients with panic disorder.
    Schneider S; Unnewehr S; In-Albon T; Margraf J
    Psychopathology; 2008; 41(3):179-86. PubMed ID: 18337628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social phobia with sudden onset--post-panic social phobia?
    Kristensen AS; Mortensen EL; Mors O
    J Anxiety Disord; 2008 May; 22(4):684-92. PubMed ID: 17728097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the need for standardization in panic disorder treatment research: survey of the literature, 1980-1992.
    Weise RE; Shear MK; Maser JD
    Anxiety; 1996; 2(6):257-64. PubMed ID: 9160633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
    Sheehan DV; Raj AB; Harnett-Sheehan K; Dorotheo J; Sheehan MF; Trehan R; Knapp E; Swiontek A; Coleman B
    Anxiety; 1996; 2(1):40-6. PubMed ID: 9160598
    [No Abstract]   [Full Text] [Related]  

  • 12. The structure of lifetime panic-agoraphobic spectrum.
    Rucci P; Miniati M; Oppo A; Mula M; Calugi S; Frank E; Shear MK; Mauri M; Pini S; Cassano GB
    J Psychiatr Res; 2009 Jan; 43(4):366-79. PubMed ID: 18499126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic effectiveness measures: sensitivity to symptom change in anxiety disorders.
    Perini SJ; Slade T; Andrews G
    J Affect Disord; 2006 Feb; 90(2-3):123-30. PubMed ID: 16337690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of the reversible monoamine oxidase-A inhibitor brofaromine in social phobia complicated by panic disorder with or without agoraphobia.
    Bakish D
    J Clin Psychopharmacol; 1994 Feb; 14(1):74-5. PubMed ID: 8151007
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing the clinical utility of agoraphobia in the context of panic disorder.
    Schmidt NB; Cromer KR
    Depress Anxiety; 2008; 25(2):158-66. PubMed ID: 17351905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-injury related phobic avoidance as predictor of nonresponse to pharmacotherapy in panic disorder with agoraphobia.
    Overbeek T; Büchold H; Schruers K; Griez E
    J Affect Disord; 2004 Mar; 78(3):227-33. PubMed ID: 15013247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardio-respiratory and other symptom clusters in panic disorder.
    Bandelow B; Amering M; Benkert O; Marks I; Nardi AE; Osterheider M; Tannock C; Tremper J; Versiani M
    Anxiety; 1996; 2(2):99-101. PubMed ID: 9160609
    [No Abstract]   [Full Text] [Related]  

  • 18. Reliability and validity of the self-report version of the Panic Disorder Severity Scale in Korea.
    Lee EH; Kim JH; Yu BH
    Depress Anxiety; 2009; 26(8):E120-3. PubMed ID: 19373866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical picture and treatment of agoraphobia with panic disorder].
    Litvintsev SV; Reznik AM; Kvashnina NV; Arbuzov AL; Krylov KE
    Voen Med Zh; 2003 Jun; 324(6):53-9. PubMed ID: 12916423
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical features of cocaine-induced panic.
    Louie AK; Lannon RA; Rutzick EA; Browne D; Lewis TB; Jones R
    Biol Psychiatry; 1996 Nov; 40(9):938-40. PubMed ID: 8896786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.